Prevalence and factors associated with reported adverse-events among patients on multi-drug-resistant tuberculosis treatment in two referral hospitals in Uganda

BACKGROUND: Multi-drug-resistant tuberculosis (MDR-TB) treatment involves toxic drugs that cause adverse events (AEs), which are life-threatening and may lead to death if not well managed. In Uganda, the prevalence of MDR-TB is increasingly high, and about 95% of the patients are on treatment. Howev...

Descripción completa

Detalles Bibliográficos
Autores principales: Ategyeka, Paul Mukama, Muhoozi, Michael, Naturinda, Racheal, Kageni, Peter, Namugenyi, Carol, Kasolo, Amos, Kisaka, Stevens, Kiwanuka, Noah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9999637/
https://www.ncbi.nlm.nih.gov/pubmed/36899299
http://dx.doi.org/10.1186/s12879-023-08085-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9999637/
https://www.ncbi.nlm.nih.gov/pubmed/36899299
http://dx.doi.org/10.1186/s12879-023-08085-3

Ejemplares similares